齐一生物科技(上海)有限公司作者
ChAT胆碱乙酰转移酶抗体说明书
资料类型 | png文件 | 资料大小 | 23828 |
下载次数 | 16 | 资料图片 | 【点击查看】 |
上 传 人 | 齐一生物科技(上海)有限公司 | 需要积分 | 0 |
关 键 词 | ChAT胆碱乙酰转移酶抗体说明书 |
- 【资料简介】
产品介绍 background:
The neurotransmitter acetycholine is synthesized from choline and acetyl-coA by the choline acetyltransferase (ChAT)enzyme,and a specific marker of cholinergic neurons.The regulation of ChATactivity is thought to be important during the development of nervous systems interactions .The reduction of ChAT activity has been found in several neurodegenerative disorders including Alzheimer’s and amyotrophic lateral sclerosis.Function:
Catalyzes the reversible synthesis of acetylcholine (ACh) from acetyl CoA and choline at cholinergic synapses.DISEASE:
Defects in CHAT are the cause of congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210]; formerly known as familial infantile myasthenia gravis 2 (FIMG2). CMSEA is an autosomal recessive congenital myasthenic syndrome. Patients have myasthenic symptoms since birth or early infancy, negative tests for anti-AChR antibodies, and abrupt episodic crises with increased weakness, bulbar paralysis, and apnea precipitated by undue exertion, fever, or excitement.Similarity:
Belongs to the carnitine/choline acetyltransferase family.Gene ID:
1103Database links:
Entrez Gene: 1103 Human
Entrez Gene: 12647 Mouse
Entrez Gene: 290567 Rat
Omim: 118490 Human
SwissProt: P28329 Human
SwissProt: Q03059 Mouse
SwissProt: P32738 Rat
Unigene: 302002 Human
Unigene: 442817 Mouse
Unigene: 45116 RatImportant Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
胆碱乙酰转移酶(Choline Acetyltransferase,ChAT 又称为:choline O-Acetyltransferase ,CHOACTase;)是催化胆碱和乙酰辅酶A转变为乙酰和辅酶A的一种酶。ChAT有M,S,R三个亚型,此抗体与三个亚型都反应。
上一篇:选购食品真空包装机关键看哪些方面
下一篇:台式真空包装机真空度不好怎么办
- 凡本网注明"来源:环保在线"的所有作品,版权均属于环保在线,转载请必须注明环保在线,https://www.hbzhan.com。违反者本网将追究相关法律责任。
- 企业发布的公司新闻、技术文章、资料下载等内容,如涉及侵权、违规遭投诉的,一律由发布企业自行承担责任,本网有权删除内容并追溯责任。
- 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
- 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。